Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$46.59 USD
+0.83 (1.81%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $46.65 +0.06 (0.13%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 31% (77 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.63 | 1.69 | 9.99 |
Current Quarter Estimate | 0.05 | 7.55 | 61.00 |
Year Ago Quarter Estimate | -1.64 | 4.52 | 54.84 |
Next Quarter Estimate | -1.79 | 8.31 | 63.00 |
Next Year Estimate | -6.52 | 45.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 23.38 | 12.60 | 15.67 |
Next Year | -34.43 | 21.90 | 11.34 |
Last 5 Years | -440.30 | 2.90 | 8.10 |
Next 5 Years | 12.00 | 15.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 4.88 |
Price/Book (MRQ) | 3.94 | 2.24 |
Price/Cash Flow (MRFY) | NA | 11.85 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1,165.69% | -9.36% |
Return on Equity (TTM) | -47.05% | -2.30% |
Debt to Equity (MRQ) | 0.00 | 22.47 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.